surmount-osa tirzepatide results SURMOUNT-5 (NCT05822830) top line announced. Adults w/ obesity + at least one of the following obesity-related diseases: htn, dyslipidemia, obstructive sleep apnea (OSA) or cvd, w/o dm weight loss of Tirzepatide SURMOUNTs obstructive sleep apnea,

Probiotics: Lacticaseibacillus rhamnosus, Limosilactobacillus reuteri, Bifidobacterium longum subsp

Novo Nordisk will file oral formulations of its GLP-1 agonist semaglutide for children and adolescents with type 2 diabetes later this year

PlexusDx explains the mechanism and practical considerations for this stack

Does compounded semaglutide expire

Zepbound is labeled as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with a body mass index (BMI) greater than 30 kg per m2, or a BMI greater than 27 kg per m2 and at least one weight-related comorbidity (e.g., hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, cardiovascular disease).1